Overview

Artemisinin-based Combination Therapy-Intermittent Preventive Treatment (ACT-IPT) Trial Among Schoolchildren in Kassena-Nankana, Ghana

Status:
Unknown status

Trial end date:
2012-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine if Artemisinin-based Combination Therapy, ACT,(artemether-lumefantrine) used as intermittent preventive treatment (IPT) alone or in combination with praziquantel, will have any effects on anemia, malaria, schistosomiasis and school sustained attention and concentration.

Phase:

Phase 4

Details

Lead Sponsor:

Navrongo Health Research Centre, Ghana

Collaborator:

DBL -Institute for Health Research and Development

Treatments:

Albendazole
Artemether
Artemether-lumefantrine combination
Artemether, Lumefantrine Drug Combination
Artemisinine
Artemisinins
Lumefantrine
Praziquantel